Using the Glasgow Benefit Inventory questionnaire to quantify the health benefits of lymphoedema treatment in patients with head and neck cancer

Table 2 Outcomes from lymphoedema treatment using the Glasgow Benefit Inventory scores

Patient	Glasgow Benefit Inventory total score	Glasgow Benefit Inventory general benefit score	Glasgow Benefit Inventory physical benefit score	Glasgow Benefit Inventory social benefit score
Patient 1	−50.0	−41.7	−50.0	−83.3
Patient 2	−19.4	−16.7	−16.7	−33.3
Patient 3	0.0	0.0	0.0	0.0
Patient 4	+ 5.6	+ 4.2	0.0	+ 16.7
Patient 5	0.0	0.0	0.0	0.0
Patient 6	+ 16.7	+ 12.5	+ 33.3	+ 16.7
Patient 7	+ 13.9	+ 12.5	+ 50.0	−16.7
Patient 8	−2.8	0.0	+ 16.7	−33.3
Patient 9	+ 11.1	+ 20.8	+ 16.7	−33.3
Patient 10	+ 8.3	+ 12.5	0.0	0.0
Patient 11	+ 16.7	+ 20.8	+ 83.3	− 66.7
Patient 12	+ 25.0	+ 25.0	+ 16.7	+ 33.3
Patient 13	+ 13.9	+ 16.7	0.0	+ 16.7
Patient 14	+ 30.6	+ 29.2	+ 33.3	+ 33.3
Patient 15^a	+ 38.9	+ 38.9	–	–
Average	+ 7.2	+ 9.0	+ 13.1	−10.7

^a This patient did not complete the questionnaire completely and has been excluded from calculation of the physical benefit and social benefit subscale scores